Tandem Diabetes Care, Inc. Share Price
NASDAQ: TNDM | Small CapTandem Diabetes Care, Inc. Stock Performance
Open $21.22 | Prev. Close $21.39 | Circuit Range N/A |
Day Range $21.22 - $21.77 | Year Range $11.46 - $29.62 | Volume 88,052 |
Average Traded $21.47 |
Tandem Diabetes Care, Inc. Share Price Today
As of 29 August 2026, Tandem Diabetes Care, Inc.'s share price is $21.45. The stock opened at $21.22, compared to its previous close of $21.39. During today's trading session, Tandem Diabetes Care, Inc.'s share price traded between $21.22 and $21.77, with an average price of $21.49. Over the past 52 weeks, the stock has recorded a high of $29.62 and a low of $11.46. In terms of performance, Tandem Diabetes Care, Inc.'s share price has declined by 15.18% over the last six months and is up 71.26% on a year-on-year basis.
Tandem Diabetes Care, Inc. Share Price Chart
Tandem Diabetes Care, Inc. Stock Fundamentals & Key Indicators
Market Cap $1.44B | PE Ratio (TTM) -7.06 | Dividend Yield N/A |
EPS (TTM) $-3.04 | Revenue (TTM) $1.01B | Return On Equity (TTM) -131.93% |
Profit Margin -20.17% | Debt to Equity 1.56 | Quarterly Earnings Growth YoY 8.97% |
Tandem Diabetes Care, Inc. Quarterly Profit & Loss
All figures in USD
Tandem Diabetes Care, Inc. Annual Profit & Loss
All figures in USD
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
Tandem Diabetes Care, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $20.01 | $21.39 | +9.69% |
Jul 2026 | $15.30 | $19.50 | +29.44% |
Jun 2026 | $19.59 | $15.06 | -12.51% |
May 2026 | $19.79 | $17.22 | -11.81% |
Apr 2026 | $18.89 | $19.52 | +1.98% |
Mar 2026 | $24.89 | $19.14 | -24.30% |
Feb 2026 | $19.86 | $25.29 | +27.02% |
Jan 2026 | $22.19 | $19.91 | -9.50% |
Dec 2025 | $19.82 | $22.00 | +4.66% |
Nov 2025 | $14.11 | $21.02 | +50.25% |
Oct 2025 | $12.29 | $13.99 | +15.14% |
Sep 2025 | $12.54 | $12.15 | -2.99% |